logo
Plus   Neg
Share
Email

AMAG Pharma To Divest Cord Blood Registry To GI Partners For $530 Mln

AMAG Pharmaceuticals Inc. (AMAG) said that it agreed to divest Cord Blood Registry to GI Partners, a private equity investment firm, for $530 million in an all cash sale. The parties expect to close the transaction in the third quarter of 2018.

AMAG said it intends to use the majority of the transaction proceeds to pay off the remaining $475 million of principal of its 7.875% Senior Notes due 2023.

The transaction has been unanimously approved by AMAG's Board of Directors. The closing of the transaction, including the timing of such closing, will be governed by the terms of the definitive agreement, including the satisfaction of customary closing conditions.

The company expects to update its 2018 financial guidance following the close of the transaction.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Following the recall of type 2 diabetes medication Metformin Hydrochloride Extended-Release (ER) by Apotex last week, the U.S. Food and Drug Administration or FDA has recommended more pharmaceutical companies, who are manufacturers of the drug formulation, to recall their products. Hundreds of Facebook employees staged a "virtual walkout" on Monday to protest the company's decision not to act on recent controversial posts by President Donald Trump on the social media platform. The employees criticized Facebook chief executive Mark Zuckerberg's decision to not moderate a post from Trump last Thursday. Doughnut companies Krispy Kreme Doughnut Corp. and Dunkin Donuts are offering free doughnuts to commemorate the upcoming National Doughnut Day on Friday, June 5. In a statement, Krispy Kreme said it is extending National Doughnut Day to National Doughnut Week, with 5 free doughnut days to choose from. The consumers will get any doughnut of choice for free, no purchase necessary, from June 1.
Follow RTT